Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Other Non-Current Assets (2016 - 2025)

Medifast (MED) has disclosed Other Non-Current Assets for 16 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 19.02% year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Dec 2025, down 19.02%, and an annual FY2025 reading of $7.8 million, down 19.02% over the prior year.
  • Other Non-Current Assets was $7.8 million for Q4 2025 at Medifast, up from $7.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $15.8 million in Q3 2023 and bottomed at $3.1 million in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $10.3 million, with a median of $11.4 million recorded in 2024.
  • The sharpest move saw Other Non-Current Assets surged 286.44% in 2022, then crashed 36.07% in 2025.
  • Year by year, Other Non-Current Assets stood at $6.5 million in 2021, then soared by 92.58% to $12.5 million in 2022, then increased by 17.61% to $14.6 million in 2023, then crashed by 34.01% to $9.7 million in 2024, then fell by 19.02% to $7.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for MED at $7.8 million in Q4 2025, $7.0 million in Q3 2025, and $8.0 million in Q2 2025.